期刊文献+

绝经后2型糖尿病女性雌激素水平与骨质疏松的相关性研究 被引量:12

Study of the Relationship Between Estrogen and Osteoporosis Among Postmenopausal Women with Type 2 Diabetes Mellitus
原文传递
导出
摘要 【目的】探讨绝经后2型糖尿病(T2DM)合并骨质疏松(OP)妇女雌激素水平及骨密度的变化及其相关性。【方法】120例绝经后女性T2DM患者根据骨密度值分为骨密度正常组即T组(62例),骨质疏松组即P组(58例)。另选取60例血糖及骨密度均正常的绝经后女性作为正常对照组,即N组(60例)。比较三组骨代谢、糖代谢及性激素等指标。【结果】P组骨碱性磷酸酶(sBAP)、骨钙素(sOC)、Ⅰ型胶原交联C 端肽(sCTx)和尿Ⅰ型胶原交联N 端肽(uNTx)明显低于T组。P组与T组、N组比较,血清卵泡刺激素(FSH)、促黄体激素(LH)升高,雌二醇(E2)下降( P<0.05)。相关性分析显示,患者O P与糖尿病病程、年龄、糖化血红蛋白(HbA1C)、空腹血糖(FPG)、FSH、LH、uNTx与肌酐(Cr)呈显著负相关,与sBAP、sOC、sCTx无相关性。【结论】绝经后T2DM妇女骨质疏松与糖代谢及雌激素水平有关。 [Objective]To explore the changes of estrogen level and bone density among postmenopausal women with type 2 diabetes mellitus(T2DM ) and osteoporosis (OP) and their correlation .[Methods] Postmenopausal women were divided into T2DM group(group T ,n=62) ,T2DM with osteoporosis group(group P , n =58) and normal control group(group N ,n=60) .Bone metabolism ,glucose metabolism ,sex hormone and other indicators among three groups were compared .[Results]Bone alkaline phosphatase(sBAP) ,osteocalcin (sOC) ,type I collagen cross-linked C end peptide(sCTx) and urine type I collagen cross-linked N end peptide (uNTx) of group P were obviously lower than those of group T .Compared with group T and group N ,serum FSH and LH were elevated ,but E2 was decreased in group P( P 〈0 .05) .Correlation analysis showed that bone mineral density (BMD) had significantly negative correlation with the duration of diabetes ,age ,HbA1C , FPG ,FSH ,LH and uNTx/Cr ,but no correlation with sBAP ,sOC and sCTx .[Conclusion]Osteoporosis of postmenopausal women with T2DM is related to glucose metabolism and estrogen level .
出处 《医学临床研究》 CAS 2014年第8期1561-1563,共3页 Journal of Clinical Research
关键词 骨质疏松 绝经后/并发症 糖尿病 2型/并发症 葡萄糖/代谢 雌激素类 骨密度 骨钙素 碱性磷酸酶 Osteoporosis,Postmenopausal/CO Diabetes Mellitus,Type 2/CO Glucose/ME Estrogens Bone Density Osteocalcin Alkaline Phosphatase
  • 相关文献

参考文献7

  • 1中华医学会骨质疏松和骨矿盐疾病分会.原发性骨质疏松症诊治指南(2011)[J].中国骨质疏松和骨矿盐疾病杂志,2011(1):2-17.
  • 2孙兰芳,王玉洁,王友强,周慧超,张磊,董砚虎.2型糖尿病合并骨质疏松症的危险因素分析[J].南通大学学报(医学版),2012,32(3):196-198. 被引量:36
  • 3Kung AW,Fan T,Xu L,et al.Factors influencing diagnosisand treatment of osteoporosis after a fragility fracture amongpostmenopausal women in Asian countries:a retrospectivestudy[J].BMC Womens Health,2013,13(1):7.
  • 4Tryniszewski W,Gadzicki M,Gorska-Chrzostek M,et al.Bone metabolism assessment,bone metabolism index designa-tion and the determination of its normal values range in younghealthy women[J],Med Sci Monit,2011,17(10):CR563-71.
  • 5Nagase S,Hashimoto Y,Small M,et al.Serum and urinebone resorption markers and pharmacokinetics of the cathepsinK inhibitor ONO-5334 after ascending single doses in postmenopausal women[J].Br J Clin Pharmacol,2012,74(6):959-70.
  • 6Ardawi MS,Rouzi AA,Al-Sibiani SA,et al.High serumsclerostin predicts the occurrence of osteoporotic fractures inpostmenopausalwomen:The center of excellence for osteopo-rosis research study[J].Bone Miner Res,2012,27(12):2592-602.
  • 7赵勤,沈丽新,张红,伍贤平,谢辉,单鹏飞,曹行之,廖二元,罗湘杭.男性骨生化指标随年龄的变化及其与骨密度的关系[J].中华医学杂志,2006,86(28):1957-1961. 被引量:6

二级参考文献25

  • 1刘红,廖二元,伍贤平,张红,罗湘杭,谢辉,曹行之,刘石平.正常女性与年龄相关的骨转换生化指标和骨密度的关系[J].中华内科杂志,2004,43(11):805-809. 被引量:27
  • 2郭丽娟,罗湘杭,伍贤平,谢辉,周后德,张红,曹行之,廖二元.绝经后妇女血清基质金属蛋白酶-1、-2和组织金属蛋白酶抑制因子-1水平及其与骨密度及骨转换生化指标的关系[J].中华医学杂志,2005,85(11):734-737. 被引量:12
  • 3单鹏飞,伍贤平,廖二元,张红,罗湘杭,曹行之,谢辉,刘石平.女性骨代谢转换生化指标和骨密度随龄变化及其相互关系[J].中华老年医学杂志,2005,24(6):431-434. 被引量:20
  • 4Swaninathan R. Biochemical markers of bone turnover. Clin Chim Acta, 2001, 313: 95-105.
  • 5Lofman O, Magnusson P, Toss G, et al. Common biochemical markers of bone turnover predict future bone loss: a 5-year follow-up study. Clin Chim Acta, 2005,356:67-75.
  • 6Nishizawa Y, Nakamura T, Ohta H, et al. Guidelines for the use of biochemical markers of bone turnover in esteoporesis (2004). J Bone Miner Metab, 2005,23 : 97-104.
  • 7Iki M, Akiba T, Matsumoto T, et al . Reference database of biochemical markers of bone turnover for the Japanese female population. Japanese Population-based Osteoporosis (JPOS) Study.Osteoporos Int, 2004,15:981-991.
  • 8Papakitsou EF, Margioris AN, Dretakis KE, et al. Body mass index(BMI) and parameters of bone formation and resorption in postmenopausal women. Maturitas, 2004,47 : 185-193.
  • 9Miller PD, Baran DT, Bilezkian J, et al. Practical clinical application of biochemical markers of bone turnover. J Clin Densitometry, 1999,2 : 323 -342.
  • 10Szulc P, Garnero P, Munoz F, et 81. Cross-sectional evaluation of bone metabolism in men. J Bone Miner Res,2001,16:1642-1650.

共引文献48

同被引文献85

引证文献12

二级引证文献73

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部